Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Inside DOE's Effort to Use AI for Nuclear Waste Cleanup
Eric Pierce explains how Savannah River National Laboratory is using AI to modernize environmental monitoring and waste cleanup.
12m listen -
Wellness Tips for Cyber Leaders at Home
Avni Desai is a dedicated professional at CGI, where she brings a thoughtful blend of leadership, strategic insight and a people‑centered approach to her work.
46m watch -
How Scientists Are Using AI to Analyze the Universe
AstroAI uses AI to identify unexpected patterns in astronomical data, helping scientists uncover new space phenomena.
13m watch -
Inside Federal Acquisition and the Future of Cloud Buying
GSA’s Jonathan Plante discusses how federal cloud acquisition is shifting toward consolidation, transparency, cybersecurity and modernization.
9m watch
